Niadyne Overview

  • Founded

  • 1997

Founded
  • Status

  • Private

  • Latest Deal Type

  • Debt

  • Financing Rounds

  • 3

Niadyne General Information

Description

Developer of various skin care products for the treatment and prevention of sun damage to skin. The company offers day therapy, night treatment, facial cleanser and facial scrub skin care products through physicians and other products for scalp and hair follicle function, and optimization of cholesterol and other blood lipids.

Contact Information

Website
www.nia24.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Personal Products
Primary Office
  • 285 Madison Avenue
  • Suite 1200
  • New York, NY 10017
  • United States
+1 (866) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Niadyne Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Niadyne‘s full profile, request access.

Request a free trial

Niadyne Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of various skin care products for the treatment and prevention of sun damage to skin. The company offers day t
Personal Products
New York, NY
000000000

000000

a aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea c
00000000 00000000
New York, NY
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Niadyne Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000000 Private Equity-Backed New York, NY 000 000000000000
You’re viewing 1 of 1 competitors. Get the full list »

Niadyne Patents

  • 33

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Niadyne Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20020156134-A1 Inhibiting production of advanced glycosylation end products by administering a penicillamine Abandoned 14-Apr-2000 0000000000 0
US-6417235-B2 Inhibiting production of advanced glycosylation end products in a patient comprising administering to the patient d-penicillamine, l-penicillamine, and d,l-penicillamine Expired - Lifetime 14-Apr-2000 0000000000 0
US-20010051658-A1 Inhibiting production of advanced glycosylation end products in a patient comprising administering to the patient d-penicillamine, l-penicillamine, and d,l-penicillamine Granted 14-Apr-2000 0000000000
US-6924299-B2 Applying vasodilator to skin Expired - Lifetime 14-Apr-2000 0000000000 0
US-20020034482-A1 Applying vasodilator to skin Granted 14-Apr-2000 A61K31/445
To view Niadyne’s complete patent history, request access »

Niadyne Executive Team (3)

Name Title Board Seat Contact Info
Richard Brown Co-Founder, Chairman & Chief Executive Officer
Myron Jacobson Ph.D Co-Founder & Chief Scientific Officer
You’re viewing 2 of 3 executive team members. Get the full list »

Niadyne Board Members (1)

Name Representing Role Since
0000000 00000 Niadyne Co-Founder, Chairman & Chief Executive Officer 000 0000
To view Niadyne’s complete board members history, request access »